Effect of a traditional Chinese medicine Liu Wei Di Huang Wan on the activities of CYP2C19, CYP2D6 and CYP3A4 in healthy volunteers

Xenobiotica

Volumn 42, Issue 6, 2012, Pages 596-602

  Chen, Y ^a   Ouyang, D S ^a   Kang, Z ^b   Yang, G P ^a   Tan, Z R ^a   Zhou, G ^a   Yan, J ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN CHILDREN'S HOSPITAL   (China)

Author keywords

CYP2C19; CYP2D6; CYP3A4; drug interaction; Liu Wei Di Huang Wan

Indexed keywords

CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; DRUG METABOLIZING ENZYME; HERBACEOUS AGENT; LIU WEI DI HUANG WAN; MIDAZOLAM; OMEPRAZOLE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; DRUG URINE LEVEL; ENZYME ACTIVITY; GENOTYPE; HERB DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PILL;

ADULT; ARYL HYDROCARBON HYDROXYLASES; CHINA; CROSS-OVER STUDIES; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 CYP3A; DEXTROMETHORPHAN; DRUGS, CHINESE HERBAL; GENOTYPE; HERB-DRUG INTERACTIONS; HUMANS; MALE; MIDAZOLAM; OMEPRAZOLE; PLACEBOS;

EID: 84860566800     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2011.644596     Document Type: Article

References (21)

1. Begas E, Kouvaras E, Tsakalof A, Papakosta S, Asprodini EK. (2007). In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios. Biomed Chromatogr 21:190-200.
2. Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, Teitel CH, Massengill JP, Lawsen MF, Kadlubar FF. (1992). Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 2:116-127.
3. Chen Y, Kang Z, Yan J, Yang GP, Tan ZR, Zhou G, Ouyang DS. (2010). Liu wei di huang wan, a well-known traditional Chinese medicine, induces CYP1A2 while suppressing CYP2A6 and N-acetyltransferase 2 activities in man. J Ethnopharmacol 132:213-218.
4. Cheng JT, Liu IM, Chi TC, Su HC, Chang CG. (2001). Stimulation of insulin release in rats by Die-Huang-Wan, a herbal mixture used in Chinese traditional medicine. J Pharm Pharmacol 53:273-276.
5. Goldstein JA, de Morais SM. (1994). Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4:285-299.
6. Hsieh MT, Cheng SJ, Lin LW, Wang WH, Wu CR. (2003). The ameliorating effects of acute and chronic administration of LiuWei Dihuang Wang on learning performance in rodents. Biol Pharm Bull 26:156-161.
7. Hsu JH, Wu YC, Liu IM, Cheng JT. (2007). Dioscorea as the principal herb of Die-Huang-Wan, a widely used herbal mixture in China, for improvement of insulin resistance in fructose-rich chow-fed rats. J Ethnopharmacol 112:577-584.
8. Kim KA, Lee JS, Park HJ, Kim JW, Kim CJ, Shim IS, Kim NJ, Han SM, Lim S. (2004). Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes. Life Sci 74:2769-2779.
9. Li M, Wang W, Wang P, Yang K, Sun H, Wang X. (2010). The pharmacological effects of morroniside and loganin isolated from Liuweidihuang Wan, on MC3T3-E1 cells. Molecules 15:7403-7414.
10. Liou SS, Liu IM, Hsu SF, Cheng JT. (2004). Corni fructus as the major herb of Die-Huang-Wan for lowering plasma glucose in Wistar rats. J Pharm Pharmacol 56:1443-1447.
11. Liou SS, Liu IM, Hsu JH, Wu YC, Hsu SF, Chen JT. (2002). Release of acetylcholine by Die-Huang-Wan to enhance insulin secretion for lowering plasma glucose in Wistar rats. Auton Neurosci 100:21-26.
12. Ma MK, Woo MH, McLeod HL. (2002). Genetic basis of drug metabolism. Am J Health Syst Pharm 59:2061-2069.
13. Oesterheld JR. (1998). A review of developmental aspects of cytochrome P450. J Child Adolesc Psychopharmacol 8:161-174.
14. Shen JJ, Lin CJ, Huang JL, Hsieh KH, Kuo ML. (2003). The effect of liu-wei-di-huang wan on cytokine gene expression from human peripheral blood lymphocytes. Am J Chin Med 31:247-257.
15. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
16. Turpault S, Brian W, Van Horn R, Santoni A, Poitiers F, Donazzolo Y, Boulenc X. (2009). Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. Br J Clin Pharmacol 68:928-935.
17. Wang P, Sun H, Lv H, Sun W, Yuan Y, Han Y, Wang D, Zhang A, Wang X. (2010). Thyroxine and reserpine-induced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLC-HDMS. J Pharm Biomed Anal 53:631-645.
18. Wijnen PA, Op den Buijsch RA, Drent M, Kuijpers PM, Kuipers PM, Neef C, Bast A, Bekers O, Koek GH. (2007). Review article: The prevalence and clinical releVance of cytochrome P450 polymorphisms. Aliment Pharmacol Ther 26 (Suppl 2):211-219.
19. Wu CR, Lin LW, Wang WH, Hsieh MT. (2007). The ameliorating effects of LiuWei Dihuang Wang on cycloheximide-induced impairment of passive avoidance performance in rats. J Ethnopharmacol 113:79-84.
20. Wu YC, Hsu JH, Liu IM, Liou SS, Su HC, Cheng JT. (2002). Increase of insulin sensitivity in diabetic rats received die-huang-wan, a herbal mixture used in Chinese traditional medicine. Acta Pharmacol Sin 23:1181-1187.
21. Zheng Y. (2007). The therapeutic effects of rehmannia oral liquid for the syndrome of heat accumulation with Yin consumption in esophagus cancer patients undergoing radiotherapy-a report of 60 cases. J Tradit Chin Med 27:248-254.